Dear Editor, p73 belongs to the family of transcription factors that also includes p53 and p63. The three proteins share a significant degree of sequence homology, and these structural similarities are paralleled by a certain degree of functional overlap and all members of the family are capable of inducing cell cycle arrest and apoptosis 1 (reviewed in reference Melino et al. 2 ). Unlike p53, the p73 gene gives rise to a number of different mRNAs, which are translated into several different proteins. The different mRNAs arise either by alternative splicing or by the use of alternative promoters. Most of the splicing occurs at the 3 0 end (isoforms a to Z), in a part of the sequence that is not present in p53, and creates proteins that have different C-termini. 1, [3] [4] [5] [6] In addition, the second promoter (P2), located in intron 3, controls the expression of DNp73s. These N-terminally truncated isoforms lack the transactivation (TA) domain, but have novel sequence coded in an additional exon, exon 3 0 . 7 Moreover, additional isoforms of p73 that lack the N-terminal TA domain can also arise from alternative splicing of transcripts originating from the first exon. [8] [9] [10] While TAp73 isoforms work as transcription factors, the DNp73 isoforms that lack the transactivation domain are incapable of directly inducing gene expression and do not induce growth arrest or cell death. However, the DNp73 forms have a very important regulatory role, since they exert a dominant negative effect on p53 and TAp73 by blocking their transactivation activity, and hence their ability to induce apoptosis. 7 The relative levels of expression and more importantly the steady-state levels of the DNp73 isoforms can therefore determine the function of both TAp73 and p53. It is therefore most interesting that the DNp73 promoter (P2) contains a very efficient p53/p73 responsive element and consequently, p53 and TAp73 efficiently induce DNp73 expression. 7 This creates a dominant negative feedback loop that regulates the function of both p53 and TAp73 and can fine tune the function of p53 (reviewed in Melino et al. 2 ). Here we show that upon DNA damage, DNp73 is rapidly degraded, thus releasing the block exerted on p53 and TA p73 and allowing cell cycle arrest and apoptosis to proceed.
To analyse the stability of the DNp73, we generated a TeT-ON-inducible SAOS-2 cell line, SAOS-2(DNp73a), overexpressing this protein. Upon introduction of doxycycline in the media, SAOS-2(DNp73a) cells express DNp73a with a peak at 48 h (data not shown), but high levels of expression are reached even after 18 h of treatment (Figure 1a) . In order to study the effect of DNp73a on UV-induced apoptosis, we treated SAOS-2(DNp73a) cells with doxycycline for 18 h and then with different doses of UV (35, 70 and 140 J/m 2 ) and analysed the cells 1, 3 and 6 h after UV treatment. Unexpectedly, a Western blot for DNp73a showed that DNp73a is rapidly degraded upon UV treatment ( Figure 1a and b). Degradation is dose dependent, and is specific for the DNp73a isoform since treating SAOS-2 cells inducible for TAp73 or p53 11 with the same doses of UV does not result in a reduction of the protein levels ( Figure 1c ). To confirm that this is not an effect of UV on the mRNA levels or on the inducible system, we performed an RT-PCR specific for the overexpressed DNp73a mRNA using a primer in the HA tag sequence and one in the DNp73a sequence. As shown in Figure 1d , no changes in the mRNA levels of DNp73a or TAp73a (used as a control) are observed in UV-treated cells, confirming that the decreased protein levels are due to rapid degradation in response to UV treatment. Treatment with 35 J/ m 2 UV of SAOS2 cells transiently transfected with either DNp73a or DNp73b and collected after 6 h, shown in Figure 1e , demonstrates that the degradation is independent of the Cterminal region and common to different DN isoforms (with or without the SAM domain). In addition, since the transfected proteins are not tagged, this experiments show that the UVdependent degradation of DNp73 (Figure 1a and b) is independent of the tag.
DNp73a degradation is not only restricted to treatment with UV but is also observed with a number of different DNAdamaging agents, as shown in Figure 1f . Treatment of induced SAOS-2(DNp73a) with doxorubicin and etoposide results in the rapid disappearance of the DNp73a protein. Figure 1g shows that treatment of cells with the proteasome inhibitor MG132 completely blocks UV-dependent degradation, showing that the degradation occurs in a proteasomedependent manner.
Since it has been shown that DNp73a expression is capable of blocking p53-and TAp73-dependent apoptosis and cell cycle arrest, we investigated the effect of its degradation on these two phenomena. As shown in Figure 1h , UV treatment of SAOS2(DNp73a) induced to express DNp73a results in an increase in apoptosis paralleled by the reduction of DNp73a. Treatment with proteasome inhibitor MG132 prevents DNp73a degradation (Figure 1g ) and rescues cells from
apoptosis measured by cytofluorimetric analysis of cells stained with PI (Figure 1i) .
In order to better understand the DNp73 degradation process, we investigated DNp73 half-life. Figure 1j (panel b) shows a cycloheximide blocking experiment performed on inducible SAOS2 cells demonstrating that, unlike TAp73 (Figure 1j panel a) , DNp73 has a half-life of about 35
0 and after about 1 h of cycloheximide treatment almost all the protein is degraded. In contrast, 18 h are necessary to completely degrade the TAp73 protein. Interestingly, in the presence of cycloheximide UV treatment does not result in an accelerated degradation of DNp73 (Figure 1j , panel b), suggesting that UV-dependent DNp73 requires protein synthesis.
Since DNp73 levels can be controlled by TAp73 and p53, 7 the existence of DNp73 represents a safety system preventing inappropriate cell death. However, this direct control implies that DNp73 levels increase in response to DNA damage 12 (in a p53/TAp73-dependent manner), preventing p53 and TAp73 from exerting their action on damaged cells. It is therefore necessary that this safety block is removed when cells are irreversibly damaged. We show for the first time that DNp73 is rapidly degraded upon DNA damage, while p53 and TAp73 proteins are not. As a consequence, upon DNA damage, DNp73 levels initially rise and then decrease in a dose-dependent manner, while TAp73 and p53 levels are increased and remain high. This results in cell cycle arrest and apoptosis of damaged cells. Our results therefore demonstrate a very important role of DNp73 in controlling cell fate.
Our data also show that the DNp73 protein has a very short half-life if compared to the TAp73 isoform suggesting that DNp73 protein levels are normally kept very low in cells. This is very important since DNp73 has been shown to have transforming activity, 13, 14 and high levels of DNp73 have been associated with a number of tumours 15 and/or with poor prognosis. 2 ) were blotted and stained using the anti-p73 antibody (Neomarker, Ab-4). Both DNp73 isoforms are degraded upon UV treatment. (f) Western blot analysis using anti-HA antibody (BABCO, HA-11) of SAOS2(DNp73a) cells. Cells were treated with doxycycline for 24 h, doxycycline was then removed and cells were harvested immediately (induced) or after 24 h of treatment with Doxorubicin (1 and 3 mM) or Etoposide (25 and 50 mM). We also included a non induced control (NI) and a nonirradiated control collected 24 h after removing doxycycline (24 h). (g) DNp73a expression was induced by a 24 h doxycycline treatment, doxycycline was then removed and cells were preincubated 3 h with the proteasome inhibitors MG132 (10 mM), and then treated with UV (140 J/m 2 ) and harvested after 6 h and analysed by immunoblotting using an anti-HA antibody (BABCO, HA-11). A Non irradiated control treated with MG132 was also collected after 6 h (MG132). (h) Western blot analysis of SAOS-2(DNp73a) cells induced with doxycycline for 24 h, treated with UV (70 J/m 2 ) and collected after 1, 3 or 6 h. Part of the cells were collected for apoptosis analysis fixed in 70% ethanol. Hypodiploid events were evaluated by flow cytometry using a propidium iodide (PI) staining on a FACS-Calibur flow cytometer (Becton-Dickinson, CA, USA). We also included a non induced control (NI) and a nonirradiated control collected 6 h after removing doxycycline (6 h). (i) SAOS-2(DNp73a) cells induced with doxycycline for 24 h were pretreated with MG132 for 3 h (I) or directly irradiated with UV (70 J/m 2 ). Cells were collected after 6 h and fixed in 70% ethanol. Apoptosis was evaluated as above. (j) Densitometry analysis of a Western blot for HA-DNp73 and HA-TAp73 (performed as described above). DNp73aexpression was induced by a 24 h doxycycline treatment, doxycycline was then removed and cells were irradiated (') with UV (140J/m 2 ) or not treated (E). Cells were treated with 20 mg/ml cycloheximide and harvested at different time points. Western blot analysis of HA-DNp73 and HA-TAp73 was performed as described above, and densitometry analysis was normalized by tubulin levels
